STEPS TAKEN AFTER GRANTING THE MARKETING AUTHORISATION 
For procedures finalised after 1 March 2004 please refer to module 8B. 
• 
• 
• 
• 
• 
• 
• 
The MAH submitted on 20 August 1998 an application to obtain a marketing authorisation in 
accordance  with  Annex  II  of  Commission  Regulation  (EC)  No  542/95  of  10  March  1995 
(part vi) as amended, falling within the scope of Part A of the Annex of the Council regulation 
EC  No.  2309/93.  The  procedure  started  on  21  August  1998,  supplementary  information  was 
supplied  by  the  MAH  on  11  December  1998,  the  Applicant  gave  oral  explanations  on  16 
December 1998, and a positive opinion was adopted by the CPMP on 16 December 1998. The 
a  Commission  Decision  on  29  March  1999 
European  Commission  granted 
(EMEA/H/C/136/X/01). 
The  MAH  submitted  on  20  August  1998  an  application  for  a  Type  II  variation,  pursuant  to 
Article 6 of Commission Regulation (EC) No. 542/95 of 10 March 1995 as amended, in order to 
apply for a change of the SPC and PIL. The procedure started on 21 August 1998 and a positive 
opinion was adopted by the CPMP on 22 October 1998. The European Commission granted a 
Commission Decision on 1 February 1999 (EMEA/H/C/136/II/02). 
Pursuant  to  Article  13(2)  of  Council  Regulation  (EEC)  No  2309/93  and  part  4G  of  Annex  to 
Council  Directive  75/318/EEC,  the  MAH  provided  in  the  foreseen  timeframe  the  reports  of 
ongoing studies according to the specific obligations stated in the Annex II of the Commission 
Decision. The MAH submitted to the EMEA the documentation, which formed the basis of the 
first  annual  re-assessment  of  the  benefit/risk  profile  for  Rebif.  The  Rapporteur’s  annual 
assessment report was circulated to all CPMP Members on 9 June 1999. During the June 1999 
CPMP plenary meeting, the CPMP agreed with the Rapporteur’s assessment report and adopted 
a  positive  opinion  on  the  annual  re-assessment  of  the  specific  obligations  and  the  benefit/risk 
ratio,  stating  that  no  amendments  of  Annexes  I  and  III  to  the  Community  Marketing 
Authorisation  are  necessary  and  that  the  marketing  authorisation  should  remain  under 
exceptional  circumstances.  The  European  Commission  granted  a  Commission  Decision  on 
3 December 1999 (EMEA/H/C/136/S/03). 
The MAH submitted on 10 May 1999 an application for a Type I variation No 13 of Annex I to 
the  regulation,  pursuant  to  Article  4  of  Commission  Regulation  (EC)  No.  542/95  of 
10 March 1995  as  amended,  in  order  to  apply  for  a  change  (scale-up)  of  the  manufacturing 
process.  The  procedure  started  on  21  May  1999  and  a  positive  opinion  was  adopted  by  the 
CPMP  on  28 July 1999  (EMEA/H/C/136/I/05).  The  European  Commission  granted  a 
Commission Decision on 3 August 1999. 
The MAH submitted on 10 May 1999 an application for a Type I variation No 12 of Annex I to 
the  regulation,  pursuant  to  Article  4  of  Commission  Regulation  (EC)  No.  542/95  of 
10 March 1995 as amended, in order to apply for minor changes to the manufacturing process. 
The procedure started on 21 May 1999, supplementary information was supplied by the MAH 
on  19 July  1999,  and  a  positive  opinion  was  adopted  by  the  CPMP  on  22  September  1999 
(EMEA/H/C/136/I/06).  The  European  Commission  granted  a  Commission  Decision  on 
5 October 1999. 
The MAH submitted on 25 August 1999 an application for a variation, pursuant to Article 10(3) 
of  Council  Directive  No.  92/27/EEC  of  31  March  1992,  as  amended  in  order  to  apply  for  a 
change  in  the  PIL,  not  connected  with  the  SPC.  The  procedure  started  on  31  August,  and  a 
positive  opinion  was  adopted  by  the  CPMP  on  7  October  1999  (EMEA/H/C/136/N/07).  The 
European Commission granted a Commission Decision on 14 December 1999. 
The  MAH  submitted  on  1  September  1999  an  application  for  a  Type  I  variation,  pursuant  to 
Article 4 of Commission Regulation (EC) No. 542/95 of 10 March 1995 as amended, in order to 
apply  for  an  extension  of  the  shelf  life  from  12-24  months.  The  procedure  started  on 
7 September  1999,  and  a  positive  opinion  was  adopted  by  the  CPMP  on  7  October  1999 
1/3 
EMEA 2005 
 
 
 
 
 
 
 
 
 
 
 
 
 
• 
• 
• 
• 
• 
• 
• 
(EMEA/H/C/136/I/08).  The  European  Commission  granted  a  Commission  Decision  on 
14 December 1999. 
The  MAH  submitted  on  9  September  1999  an  application  for  a  Type  II  variation,  pursuant  to 
Article 6 of Commission Regulation (EC) No. 542/95 of 10 March 1995 as amended, in order to 
apply for changes to active substance specifications and test methods. The procedure started on 
23 September 1999, and a positive opinion was adopted  by the CPMP on  18 November  1999 
(EMEA/H/C/136/II/09).  The  European  Commission  granted  a  Commission  Decision  on 
2 December 1999. 
The  MAH  submitted  on  20  October  1999  an  application  for  a  Type  I  variation,  pursuant  to 
Article 4 of Commission Regulation (EC) No. 542/95 of 10 March 1995 as amended, in order to 
apply  for  a  change  of  name  of  the  manufacturer  responsible  for  batch  release.  The  procedure 
started  on  25  October  1999,  and  a  positive  opinion  was  adopted  by  the  CPMP  on 
12 November 1999  (EMEA/H/C/136/I/10).  The  European  Commission  granted  a  Commission 
Decision on 20 January 2000. 
The  MAH  submitted  on  11  February  2000  an  application  for  a  Type  I  variation,  pursuant  to 
Article 4 of Commission Regulation (EC) No. 542/95 of 10 March 1995 as amended, in order to 
apply  for  a  change  of  to  the  manufacturing  process  of  the  active  substance.  The  procedure 
started  on  18  February  2000,  and  a  positive  opinion  was  adopted  by  the  CPMP  on 
16 March 2000.  (EMEA/H/C/136/I/12).  The  European  Commission  granted  a  Commission 
Decision on 11 April 2000. 
The MAH submitted on 16 May 2000 an application for a Type II variation, pursuant to Article 
6 of Commission Regulation (EC) No. 542/95 of 10 March 1995 as amended, in order to apply 
for  changes  in  the  SPC  and  PL,  based  on  the  results  of  the  extension  study  in  RRMS.  The 
procedure  started  on  26  May  2000,  and  a  positive  opinion  was  adopted  by  the  CPMP  on 
19 October  2000  (EMEA/H/C/136/II/13).  The  European  Commission  granted  a  Commission 
Decision on 22 January 2001. 
Pursuant  to  Article  13(2)  of  Council  Regulation  (EEC)  No  2309/93  and  part  4G  of  Annex  to 
Council  Directive  75/318/EEC,  the  MAH  provided  in  the  foreseen  timeframe  the  reports  of 
ongoing studies according to the specific obligations stated in the Annex II of the Commission 
Decision. The MAH submitted to the EMEA the documentation, which formed the basis of the 
second  annual  re-assessment  of  the  benefit/risk  profile  for  Rebif.  The  Rapporteur’s  annual 
assessment report was circulated to all CPMP Members on 26 June 2000. During the July 2000 
CPMP plenary meeting, the CPMP agreed with the Rapporteur’s assessment report and adopted 
a  positive  opinion  on  the  annual  re-assessment  of  the  specific  obligations  and  the  benefit/risk 
ratio,  stating  that  no  amendments  of  Annexes  I  and  III  to  the  Community  Marketing 
Authorisation are necessary. Since all specific obligations stated in Annex II of the Commission 
Decision  have  been  fulfilled,  the  CPMP  recommended  that  the  Marketing  Authorisation  for 
Rebif was released from the status “under exceptional circumstances”(EMEA/H/C/136/S/14). 
The MAH submitted on 13 July 2000 an application for a Type I variation No 12 of Annex I to 
the  regulation,  pursuant  to  Article  4  of  Commission  regulation  (EC)  No.  542/95  of  10  March 
1995,  as  amended,  in  order  to  apply  for  minor  changes  to  the  active  substance  production 
process.  The  procedure  started  on  28  July  2000,  and  a  positive  opinion  was  adopted  by  the 
CPMP  on  21  September  2000  (EMEA/H/C/136/I/16).  The  European  Commission  granted  a 
Commission Decision on 16 October 2000. 
The MAH submitted on 13 July 2000 an application for a Type II variation, pursuant to Article 
6 of Commission regulation (EC) No. 542/95 of 10 March 1995, as amended, in order to apply 
for an amendment in the specifications of the active substance. The procedure started on 28 July 
2000,  and  a  positive  opinion  was  adopted  by  the  CPMP  on  21  September  2000 
(EMEA/H/C/136/II/17).  The  European  Commission  granted  a  Commission  Decision  on 
16 October 2000. 
2/3 
EMEA 2005 
 
 
 
 
 
 
 
 
 
 
 
 
• 
The  MAH  submitted  on  28  July  2000  an  application  for  a  Notification  of  a  Type  I  variation, 
pursuant  to  Article  4  of  Commission  regulation  (EC)  No.  542/95  of  10  March  1995,  as 
amended, in order to apply for minor changes to the active substance production process. The 
procedure  started  on  4  August  2000,  and  a  positive  opinion  was  signed  on  1  September  2000 
(EMEA/H/C/136/I/18).  The  European  Commission  granted  a  Commission  Decision  on 
12 September 2000. 
Subsequent post Marketing Authorisation applications agreed upon are summarised in the table below: 
Scope 
Application 
number 
Type of 
modification1 
Notification/ 
Opinion 
issued on2 
Extension of Indication 
Change in or addition of manufacturer(s) of active substance 
Change in or addition of manufacturing site(s) por part or all of the 
manufacturing process 
Changes to comply with supplements to pharmacopoeias 
Change in storage conditions 
Change(s) to the manufacturing process for the active substance 
Minor change in labelling or package leaflet not connected with the 
SPC (Art. 61.3 Notification) 
Change in supplier of an intermediate compound used in 
manufacture of the active substance 
Change in the name and/or address of the marketing authorisation 
holder 
Change in or addition of manufacturing site(s) for part or all of the 
manufacturing process 
Extension of shelf-life or retest period of the active substance 
Change(s) to the manufacturing process for the active substance 
Update of Summary of Product Characteristics and Package Leaflet 
Change in the batch size of finished product 
Minor change in labelling or package leaflet not connected with the 
SPC (Art. 61.3 Notification) 
Change(s) to the test method(s) and/or specifications for the finished 
product 
Change in the procedure of active substance 
Change in the supplier of an intermediate compound used in 
manufacture of active substance 
Minor  change of manufacturing process of the active substance 
Change in specification of starting material/intermediate used in 
manuf. of the active substance 
Update of Summary of Product Characteristics and Package Leaflet 
Minor change in the package leaflet not connected with the SPC 
Renewal 
Change(s) to the test method(s) and/or specifications for the active 
substance 
Change in container shape 
Change(s) to the test method(s) and/or specifications for the active 
substance 
Replacement/add. of manufacturing site: Secondary packaging site 
Change in in-process controls applied during the manufacture of the 
product 
Change in in-process controls applied during the manufacture of the 
product 
Update of Summary of Product Characteristics and Package Leaflet 
II/11 
I/15 
I/II/19 
II 
I 
I/II 
I/20 
I/21 
X-22 
N-24 
I/25 
I/26 
I/27 
I/28 
II/29 
II/30 
I/31 
N/32 
II/33 
I/34 
I/35 
I/36 
I/37 
II/38 
N/39 
R/40 
II/42 
I/43 
II/44 
I/45 
I/46 
I/48 
II/49 
I 
I 
X 
N 
I 
I 
I 
I 
II 
II 
I 
N 
II 
I 
I 
I 
I 
II 
N 
R 
II 
I 
II 
I 
I 
I 
II 
Commission 
Decision 
Issued/amen
ded on 
21.11.01 
20.03.01 
20.12.00 
13.03.01 
16.01.03 
03.10.01 
25.07.01 
14.12.00 
14.12.00 
28.02.01 
11.06.01 
17.10.02 
21.08.01 
09.08.01 
07.09.01 
26.07.01 
18.09.01 
17.08.01 
07.09.01 
21.09.01 
15.11.01 
01.02.02 
11.03.02 
28.11.01 
17.05.02 
11.02.02 
02.04.02 
25.07.02 
31.07.02 
25.07.02 
22.08.02 
22.08.02 
11.12.02 
19.03.03 
27.01.03 
19.03.03 
22.05.03 
20.08.03 
22.10.03 
01.12.03 
01.12.03 
20.10.03 
31.07.02 
10.09.02 
10.09.02 
13.12.02 
25.06.03 
04.03.03 
04.06.03 
27.05.03 
18.09.03 
30.10.03 
- 
- 
- 
17.12.03 
23.02.04 
1 In accordance with Commission Regulation (EC) No. 542/95 of 10 March 1995, as amended: I refers to a minor variation 
(Type I variation); II refers to a major variation (Type II variation); I/II refers to a minor variation following the procedure 
set out in Article 6, 7 and 8 of the Regulation; X refers to an Annex II application. 
T refers to a transfer of a Marketing Authorisation in accordance with Commission Regulation (EC) No 2141/96 of 7 
November 1996.  
N refers to a notification in accordance with Article 10(3) of Council Directive 92/27/EEC of 31 March 1992. 
2 For Notifications and Type I variations, the date of entry into force of the change is the EMEA Notification date. The 
Commission Decision will be amended accordingly. 
3/3 
EMEA 2005 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                      
 
